Man, thyroid carcinoma is a big deal these days. It’s prevalent. Precision therapies totally changed the game for patients battling thyroid carcinoma, hands down.

Here’s something new – they’re using Lenvatinib drug now. It’s a novel kinase inhibitor, different from the previous medication, sorafenib. This article explores the comparative effectiveness and adverse reactions of lenvatinib vs sorafenib in thyroid cancer treatment.

Targeted Therapy

Specific therapy is like a exact tool for cancer. It’s drugs that go straight after those targeted pathways. (